As the COVID-19 pandemic continues to unfold, U.S. public company compensation committees face unique challenges as they focus on retaining and appropriately incentivizing employees while evaluating the impact of the pandemic on the company. This client alert provides a high-level overview of some key issues that compensation committees should be focusing on in this environment.
The post Key Considerations for U.S. Public Company Compensation Committees in Light of COVID-19 appeared first on Life Sciences Perspectives.